O	O	0	10	Activation	Activation	B-NP	NN	O	10	SUB	O
O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
O	O	14	17	the	the	B-NP	DT	O	9	NMOD	O
T4	B-Entity	18	23	human	human	I-NP	JJ	B-DNA	9	NMOD	B-DNA
T4	I-Entity	24	40	immunodeficiency	immunodeficiency	I-NP	NN	I-DNA	9	NMOD	I-DNA
T4	I-Entity	41	46	virus	virus	I-NP	NN	I-DNA	9	NMOD	I-DNA
T4	I-Entity	47	51	type	type	I-NP	NN	I-DNA	9	NMOD	I-DNA
T4	I-Entity	52	53	1	1	I-NP	CD	I-DNA	9	NMOD	I-DNA
T4	I-Entity	54	62	enhancer	enhancer	I-NP	NN	I-DNA	2	PMOD	I-DNA
O	O	63	65	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	66	69	not	not	O	RB	O	10	VMOD	O
O	O	70	79	dependent	dependent	B-ADJP	JJ	O	10	PRD	O
O	O	80	82	on	on	B-PP	IN	O	12	AMOD	O
T1	B-Protein	83	87	NFAT	NFAT	B-NP	NN	B-protein	15	NMOD	B-protein
T1	I-Protein	87	88	-	-	B-NP	HYPH	O	13	PMOD	O
T1	I-Protein	88	89	1	1	I-NP	CD	O	15	NMOD	O
O	O	89	90	.	.	O	.	O	10	P	O

O	O	92	95	The	The	B-NP	DT	O	2	NMOD	O
O	O	96	104	function	function	I-NP	NN	O	18	SUB	O
O	O	105	107	of	of	B-PP	IN	O	2	NMOD	O
O	O	108	109	a	a	B-NP	DT	O	9	NMOD	O
O	O	110	118	putative	putative	I-NP	JJ	O	9	NMOD	O
T2	B-Protein	119	123	NFAT	NFAT	I-NP	NN	B-protein	9	NMOD	B-protein
T2	I-Protein	123	124	-	-	B-NP	HYPH	O	9	NMOD	O
T2	I-Protein	124	125	1	1	I-NP	CD	B-DNA	9	NMOD	B-DNA
T5	B-Entity	126	130	site	site	I-NP	NN	I-DNA	3	PMOD	I-DNA
O	O	131	133	in	in	B-PP	IN	O	9	NMOD	O
O	O	134	137	the	the	B-NP	DT	O	17	NMOD	O
T6	B-Entity	138	143	human	human	I-NP	JJ	B-DNA	17	NMOD	B-DNA
T6	I-Entity	144	160	immunodeficiency	immunodeficiency	I-NP	NN	I-DNA	17	NMOD	I-DNA
T6	I-Entity	161	166	virus	virus	I-NP	NN	I-DNA	17	NMOD	I-DNA
T6	I-Entity	167	171	type	type	I-NP	NN	I-DNA	17	NMOD	I-DNA
T6	I-Entity	172	173	1	1	I-NP	CD	I-DNA	17	NMOD	I-DNA
T6	I-Entity	174	182	enhancer	enhancer	I-NP	NN	I-DNA	10	PMOD	I-DNA
O	O	183	186	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	187	191	been	be	I-VP	VBN	O	18	VC	O
O	O	192	200	analyzed	analyze	I-VP	VBN	O	19	VC	O
O	O	200	201	.	.	O	.	O	18	P	O

O	O	202	212	Activation	Activation	B-NP	NN	O	9	SUB	O
O	O	213	215	by	by	B-PP	IN	O	1	NMOD	O
O	O	216	219	the	the	B-NP	DT	O	8	NMOD	O
O	O	220	221	T	T	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	221	222	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
O	O	222	226	cell	cell	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	227	234	antigen	antigen	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	235	243	receptor	receptor	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	244	246	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	247	254	minimal	minimal	B-ADJP	JJ	O	9	PRD	O
O	O	255	257	in	in	B-PP	IN	O	10	AMOD	O
O	O	258	264	Jurkat	Jurkat	B-NP	NN	B-cell_line	13	NMOD	B-cell_line
O	O	265	270	cells	cell	I-NP	NNS	I-cell_line	11	PMOD	I-cell_line
O	O	271	274	and	and	O	CC	O	9	VMOD	O
O	O	275	277	is	be	B-VP	VBZ	O	9	VMOD	O
O	O	278	286	mediated	mediate	I-VP	VBN	O	15	VC	O
O	O	287	289	by	by	B-PP	IN	O	16	VMOD	O
O	O	290	293	the	the	B-NP	DT	O	21	NMOD	O
T7	B-Entity	294	299	kappa	kappa	I-NP	NN	B-DNA	21	NMOD	B-DNA
T7	I-Entity	300	301	B	B	I-NP	NN	I-DNA	21	NMOD	I-DNA
T7	I-Entity	302	307	sites	site	I-NP	NNS	I-DNA	17	PMOD	I-DNA
O	O	307	308	.	.	O	.	O	9	P	O

O	O	309	312	The	The	B-NP	DT	O	3	NMOD	O
O	O	313	321	putative	putative	I-NP	JJ	O	3	NMOD	O
T3	B-Protein	322	326	NFAT	NFAT	I-NP	NN	B-protein	6	NMOD	B-protein
T3	I-Protein	326	327	-	-	B-NP	HYPH	O	6	NMOD	O
T3	I-Protein	327	328	1	1	I-NP	CD	O	6	NMOD	O
T8	B-Entity	329	335	region	region	I-NP	NN	O	7	SUB	O
O	O	336	338	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	339	342	not	not	I-VP	RB	O	7	VMOD	O
O	O	343	351	required	require	I-VP	VBN	O	7	VC	O
O	O	352	355	for	for	B-PP	IN	O	9	VMOD	O
O	O	356	359	the	the	B-NP	DT	O	12	NMOD	O
O	O	360	368	response	response	I-NP	NN	O	10	PMOD	O
O	O	369	371	to	to	B-PP	TO	O	12	NMOD	O
O	O	372	376	anti	anti	B-NP	AFX	O	16	NMOD	O
O	O	376	377	-	-	I-NP	HYPH	O	16	P	O
T9	B-Entity	377	380	CD3	CD3	B-NP	NN	B-protein	13	PMOD	B-protein
O	O	381	383	or	or	B-PP	CC	O	13	PMOD	O
O	O	384	386	to	to	B-PP	TO	O	13	PMOD	O
O	O	387	395	mitogens	mitogen	B-NP	NNS	B-protein	18	PMOD	B-protein
O	O	396	398	in	in	B-PP	IN	O	19	NMOD	O
O	O	399	400	T	T	B-NP	NN	B-cell_type	23	NMOD	B-cell_type
O	O	400	401	-	-	I-NP	HYPH	I-cell_type	23	NMOD	I-cell_type
O	O	401	405	cell	cell	I-NP	NN	I-cell_type	34	NMOD	I-cell_type
O	O	405	406	,	,	I-NP	,	O	34	P	O
O	O	407	408	B	B	I-NP	NN	B-cell_type	27	NMOD	B-cell_type
O	O	408	409	-	-	I-NP	HYPH	I-cell_type	27	NMOD	I-cell_type
O	O	409	413	cell	cell	I-NP	NN	I-cell_type	34	NMOD	I-cell_type
O	O	413	414	,	,	O	,	O	34	P	O
O	O	415	417	or	or	O	CC	O	34	NMOD	O
O	O	418	426	monocyte	monocyte	B-NP	NN	B-cell_type	34	NMOD	B-cell_type
O	O	426	427	/	/	O	SYM	O	34	NMOD	O
O	O	427	437	macrophage	macrophage	B-NP	NN	B-cell_line	34	NMOD	B-cell_line
O	O	438	446	leukemia	leukemia	I-NP	NN	I-cell_line	34	NMOD	I-cell_line
O	O	447	452	lines	line	I-NP	NNS	I-cell_line	20	PMOD	I-cell_line
O	O	452	453	,	,	O	,	O	7	P	O
O	O	454	457	nor	nor	O	CC	O	7	VMOD	O
O	O	458	460	is	be	O	VBZ	O	7	VMOD	O
O	O	461	463	it	it	B-NP	PRP	O	37	SUB	O
O	O	464	465	a	a	B-NP	DT	O	45	NMOD	O
T10	B-Entity	466	469	cis	cis	I-NP	NN	B-DNA	45	NMOD	B-DNA
T10	I-Entity	469	470	-	-	B-PP	HYPH	I-DNA	45	NMOD	I-DNA
T10	I-Entity	470	476	acting	act	B-NP	VBG	I-DNA	45	NMOD	I-DNA
T10	I-Entity	477	485	negative	negative	I-NP	JJ	I-DNA	45	NMOD	I-DNA
T10	I-Entity	486	496	regulatory	regulatory	I-NP	JJ	I-DNA	45	NMOD	I-DNA
T10	I-Entity	497	504	element	element	I-NP	NN	I-DNA	37	PRD	I-DNA
O	O	504	505	.	.	O	.	O	7	P	O
